| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $0.6292 ▲ +1.33% | Yesterday | $0.6175 ▼ -0.56% | Tomorrow's Cytosorbents Corporation Common Stock (CTSO) setup is anchored to $0.6210 and targets $0.6292 (+1.33%). The near-term read is upside; watch $0.6396 / $0.6024 because daily realized volatility is about 6.84%. |
Tomorrow's Cytosorbents Corporation Common Stock (CTSO) setup is anchored to $0.6210 and targets $0.6292 (+1.33%). The near-term read is upside; watch $0.6396 / $0.6024 because daily realized volatility is about 6.84%. | ||||
| Week | $0.6466 ▲ +4.12% | Last Week | $0.6102 ▼ -1.73% | The 7-day Cytosorbents Corporation Common Stock model moves from $0.6102 to $0.6466 (+4.12%). It gives upside momentum context for this stock, so breaks around $0.6396 / $0.6024 matter more than a single tick. |
The 7-day Cytosorbents Corporation Common Stock model moves from $0.6102 to $0.6466 (+4.12%). It gives upside momentum context for this stock, so breaks around $0.6396 / $0.6024 matter more than a single tick. | ||||
| Month | $0.6756 ▲ +8.79% | Last Month | $0.5981 ▼ -3.69% | The 1-month Cytosorbents Corporation Common Stock target is $0.6756 (+8.79%), compared with the live reference near $0.6210. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Cytosorbents Corporation Common Stock target is $0.6756 (+8.79%), compared with the live reference near $0.6210. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $0.7189 ▲ +15.77% | Last Year | $0.5799 ▼ -6.62% | The 1-year Cytosorbents Corporation Common Stock scenario points to $0.7189 (+15.77%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Cytosorbents Corporation Common Stock scenario points to $0.7189 (+15.77%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $0.8206 ▲ +32.14% | 5 Years Ago | $0.5372 ▼ -13.50% | The 5-year Cytosorbents Corporation Common Stock view is $0.8206 (+32.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Cytosorbents Corporation Common Stock view is $0.8206 (+32.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $0.6210 | Mid |
| Daily Change | -3.74% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 65% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $0.6210 | Daily Change | -3.74% |
| Market Cap | $38.94M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.